The whole-cell patch-clamp technique was used to examine the effects of retigabine, a novel anticonvulsant drug, on the electroresponsive properties of individual neurons as well as on neurotransmission between monosynaptically connected pairs of cultured mouse cortical neurons. Consistent with its known action on potassium channels, retigabine significantly hyperpolarized the resting membrane potentials of the neurons, decreased input resistance, and decreased the number of action potentials generated by direct current injection. In addition, retigabine potentiated inhibitory postsynaptic currents (IPSCs) mediated by activation of ␥-aminobutyric acid A (GABA A ) receptors. IPSC peak amplitude, 90-to-10% decay time, weighted decay time constant, slow decay time constant, and, consequently, the total charge transfer were all significantly enhanced by retigabine in a dose-dependent manner. This effect was limited to IPSCs; retigabine had no significant effect on excitatory postsynaptic currents (EPSCs) mediated by activation of non-N-methyl-D-aspartate ionotropic glutamate receptors. A form of short-term presynaptic plasticity, paired-pulse depression, was not altered by retigabine, suggesting that its effect on IPSCs is primarily postsynaptic. Consistent with the hypothesis that retigabine increases inhibitory neurotransmission via a direct action on the GABA A receptor, the peak amplitudes, 90-to-10% decay times, and total charge transfer of spontaneous miniature IPSCs were also significantly increased. Therefore, retigabine potently reduces excitability in neural circuits via a synergistic combination of mechanisms.The novel anticonvulsant drug retigabine [D-23129; N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester] has been found to effectively reduce or block seizure activity in a wide variety of animal models of epilepsy (Dailey et al., 1995;Rostock et al., 1996;Tober et al., 1996). Retigabine is structurally different and has a higher protective index than many of the commonly prescribed anticonvulsants . Of particular interest is the recent finding that a primary mechanism of action of retigabine is the enhanced activation of heteromeric potassium channels composed of the KCNQ2 and KCNQ3 subunits (Main et al., 2000;Rundfeldt and Netzer, 2000b;Wickenden et al., 2000). It has been demonstrated that the channels formed by the KCNQ2/Q3 subunits underlie a neuronal potassium current commonly referred to as the M current (Wang et al., 1998;Shapiro et al., 2000). The M current is critical in determining resting membrane potential and neuronal excitability in many brain regions because of its sustained activation at potentials below the threshold for action potential generation (Marrion, 1997). Consistent with its ability to augment M channel currents, retigabine has been found to effectively hyperpolarize and reduce action potential generation in projection neurons located in layers II and III of the entorhinal cortex (Hetka et al., 1999).Previous work suggests that the mechanism of action...